Colgate-Palmolive (NYSE:CL) Director John T. Cahill sold 8,000 shares of the business’s stock in a transaction dated Friday, August 9th. The stock was sold at an average price of $71.43, for a total value of $571,440.00. Following the sale, the director now owns 30,326 shares in the company, valued at approximately $2,166,186.18. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website.
Shares of CL traded up $0.96 during trading hours on Tuesday, reaching $71.69. The company’s stock had a trading volume of 2,514,586 shares, compared to its average volume of 3,580,594. The company has a market cap of $61.12 billion, a price-to-earnings ratio of 24.14, a price-to-earnings-growth ratio of 4.60 and a beta of 0.76. Colgate-Palmolive has a 1-year low of $57.41 and a 1-year high of $76.41. The company has a current ratio of 1.13, a quick ratio of 0.78 and a debt-to-equity ratio of 32.25. The firm has a 50 day moving average of $72.68.
Colgate-Palmolive (NYSE:CL) last issued its earnings results on Friday, July 26th. The company reported $0.72 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.72. The company had revenue of $3.87 billion for the quarter, compared to the consensus estimate of $3.88 billion. Colgate-Palmolive had a negative return on equity of 10,821.98% and a net margin of 14.77%. The firm’s quarterly revenue was down .5% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.77 EPS. Equities research analysts anticipate that Colgate-Palmolive will post 2.84 earnings per share for the current fiscal year.
Several analysts have issued reports on CL shares. Morgan Stanley boosted their price objective on Colgate-Palmolive from $72.00 to $74.00 and gave the stock an “equal weight” rating in a report on Monday, July 29th. Deutsche Bank boosted their price objective on Colgate-Palmolive from $74.00 to $76.00 and gave the stock a “hold” rating in a report on Friday, July 12th. Macquarie boosted their price objective on Colgate-Palmolive from $65.00 to $72.00 and gave the stock a “neutral” rating in a report on Monday, April 29th. Zacks Investment Research downgraded Colgate-Palmolive from a “buy” rating to a “hold” rating and set a $77.00 price objective on the stock. in a report on Friday, June 7th. Finally, Jefferies Financial Group boosted their price objective on Colgate-Palmolive from $61.00 to $73.00 and gave the stock an “in-line” rating in a report on Monday, April 29th. They noted that the move was a valuation call. One investment analyst has rated the stock with a sell rating, twelve have issued a hold rating and five have assigned a buy rating to the stock. The stock presently has a consensus rating of “Hold” and a consensus price target of $73.13.
Several hedge funds and other institutional investors have recently made changes to their positions in the stock. Bank of New York Mellon Corp grew its stake in shares of Colgate-Palmolive by 2.9% in the 2nd quarter. Bank of New York Mellon Corp now owns 20,354,779 shares of the company’s stock valued at $1,458,828,000 after buying an additional 573,566 shares in the last quarter. Northern Trust Corp grew its stake in shares of Colgate-Palmolive by 1.4% in the 1st quarter. Northern Trust Corp now owns 10,906,808 shares of the company’s stock valued at $747,553,000 after buying an additional 146,144 shares in the last quarter. Geode Capital Management LLC grew its stake in shares of Colgate-Palmolive by 7.9% in the 4th quarter. Geode Capital Management LLC now owns 10,540,277 shares of the company’s stock valued at $626,200,000 after buying an additional 768,550 shares in the last quarter. FIL Ltd grew its stake in shares of Colgate-Palmolive by 9.6% in the 1st quarter. FIL Ltd now owns 7,972,928 shares of the company’s stock valued at $546,465,000 after buying an additional 695,987 shares in the last quarter. Finally, FMR LLC grew its stake in shares of Colgate-Palmolive by 29.1% in the 1st quarter. FMR LLC now owns 7,384,604 shares of the company’s stock valued at $506,141,000 after buying an additional 1,665,348 shares in the last quarter. 75.64% of the stock is owned by institutional investors and hedge funds.
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. It offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; and personal care products, such as liquid hand soaps, bar soaps, shower gels, deodorants and antiperspirants, skin care products, and shampoos and conditioners.
Featured Article: Capital gains and your 401(k) or IRA
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.